Php284 - Time to Hta Decision for Internationalised Medicines in Australia, Canada and Europe

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prm116 - General Perceptions of Innovative Methods for Survival Extrapolation in Oncology Among Hta in Europe, Canada and Australia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php301 - The Time Is Now for European Hta: How Will the Evolution of European Hta Impact Access to Innovative Medicines?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Increasing Transparency and the Patient Voice in HTA of New Medicines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pcn293 - What Is the Value of Real World Evidence in Oncology in Hta Appraisals in England, France, Canada and Australia?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Access to High Cost Medicines in Australia: Ethical Perspectives

Australia and New Zealand Health Policy
2008English

Hta in Central-Eastern-Southern Europe: Finding Its Way to Health Policy

International Journal of Technology Assessment in Health Care
Health Policy
2017English

HTA for Pharmaceuticals in Europe: Will the Mountain Deliver a Mouse?

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2019English

Reimbursement Decision Landscape for Orphan Drugs Across Six Hta Agencies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Passport to Safety—from Canada to Australia

Injury Prevention
EnvironmentalPublic HealthOccupational Health
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy